贝叶斯基因组全方位TWAS与脑和血液组织的参考转录组数据确定了93个阿尔茨海默病痴呆症风险基因
medRxiv : the preprint server for health sciences
|July 28, 2023
概括
这项研究通过整合来自大脑和血液组织的cis-和trans-eQTL数据来确定93个重要的阿尔茨海默病 (AD) 风险基因. 这些发现揭示了与AD痴呆相关的新生物学途径,包括50个以前未被发现的基因.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 生物信息学是一种生物信息学.
背景情况:
- 全转录组关联研究 (TWAS) 对于识别与疾病相关的基因至关重要.
- 对于阿尔茨海默氏症 (AD) 痴呆症的现有TWAS通常忽视了trans-eQTL,限制了基因发现.
- 这项研究通过结合cis和trans-eQTL来解决这个问题.
结论:
- BGW-TWAS有效地将cis-和trans-eQTL与GWAS数据集成,以识别AD痴呆风险基因.
- 这些已识别的基因为AD复杂的生物途径提供了新的见解.
- 这种方法增强了复杂疾病遗传风险因素的映射.
更多相关视频
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
897
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.0K
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Alzheimer's Disease: Overview
524
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
524
